Background High rates of vaccination worldwide are required to establish a herd immunity
and stop the current COVID-19 pandemic evolution. Vaccine hesitancy is a major barrier in …

Vaccine hesitancy forms a critical barrier to the uptake of COVID-19 vaccine in high-income
countries or regions. This review aims to summarize rates of COVID-19 hesitancy and its …

COVID-19 vaccines were approved in late 2020 and early 2021 for public use in countries
across the world. Several studies have now highlighted COVID-19 vaccination hesitancy in …

Herd immunity through vaccination is a key measure to control COVID-19 pandemic.
However, vaccine hesitancy remains a public health threat, which is still common among …

Background: The current crisis created by the coronavirus pandemic is impacting all facets
of life. Coronavirus vaccines have been developed to prevent coronavirus infection and fight …

Introduction Although many vaccines are in development and clinical trials, and at least
seven vaccines have been distributed worldwide, the world has faced a huge challenge in …

Monkeypox (MPX) has been regarded as a neglected tropic disease of Western and Central
Africa since the early 70s. However, during May 2022, an unprecedent outbreak of MPX has …

The COVID-19 pandemic and its associated vaccine have highlighted vaccine hesitancy
among healthcare workers (HCWs). Vaccine hesitancy among this group existed prior to the …

Because health care workers are a reliable source of health information, their acceptance or
rejection of COVID‐19 vaccines can influence the general population′ s uptake of COVID …

Background The outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China,
spreads globally, since its declaration by the World Health Organization (WHO) as a COVID …